切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2006, Vol. 02 ›› Issue (02) : 91 -93. doi: 10.3877/cma.j.issn.1673-5250.2006.02.109

论著

用促性腺激素释放激素类似物预处理后腹腔镜行子宫肌瘤切除术的分析
段洁, 熊俊, 郎雁, 王燕, 方敏, 武沙丽   
  1. 湖北省妇幼保健院妇产科(武汉,430074)
    湖北省妇幼保健院超声室(武汉,430074)
  • 出版日期:2006-03-21

Analysis of the efficacy of GnRH-a agonist therapy before laparoscopic hysteromyomectomy

Jie DUAN, Jun XIONG, Yan LANG, Yan WAN, Min FANG, Sha-li WU   

  1. Department of Obstetrics and Gynecology, Hubei Maternal and Child Health Hospital, Wuhan, Hubei Province, 430074, China
  • Published:2006-03-21
引用本文:

段洁, 熊俊, 郎雁, 王燕, 方敏, 武沙丽. 用促性腺激素释放激素类似物预处理后腹腔镜行子宫肌瘤切除术的分析[J]. 中华妇幼临床医学杂志(电子版), 2006, 02(02): 91-93.

Jie DUAN, Jun XIONG, Yan LANG, Yan WAN, Min FANG, Sha-li WU. Analysis of the efficacy of GnRH-a agonist therapy before laparoscopic hysteromyomectomy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2006, 02(02): 91-93.

目的

分析经用促性腺激素释放激素类似物(GnRH-a)预处理后,腹腔镜行子宫肌瘤切除术的手术效果、适应证及并发症。

方法

回顾性分析直径大于5 cm肌瘤的腹腔镜肌瘤切除术,其中28例术前给予曲普瑞林醋酸盐(diphereline,达菲林)(研究组),36例未用药(对照组),比较两组的手术时间、术中出血量及手术并发症等。

结果

①研究组中每例患者肌瘤1〜2个,共切除肌瘤32个,未用药前超声测量肌瘤平均直径为6. 5 cm;切除术后平均直径为3. 2 cm。对照组中每例患者肌瘤1〜3个,共切除肌瘤41个,术前超声测量肌瘤平均直径为5. 9 cm;切除术后测量平均直径为5. 7 cm。术前两组肌瘤直径比较,差异无显著意义(P>0. 05),切除术后两组肌瘤直径比较,研究组肌瘤直径明显缩小,肌瘤体积平均缩小率51%,两组比较差异有显著意义(P<0. 01)。②研究组中有9例进行了缝合,手术时间为(45±18)min,出血量为(60±25)ml;对照组中有12例进行了缝合,手术时间为(92±32)min,出血量为(110±105)ml,两者比较,研究组手术时间及出血量均明显减少,差异有显著意义(P<0. 01,P<0. 05)。③研究组、对照组组术后平均住院时间分别为4. 2 d及4. 8 d,术后2个月后随访,两组术前有症状者术后均改善。研究组1例术后1+ 年肌瘤复发,再次行腹腔镜子宫肌瘤切除术。

结论

对于较大体积的子宫肌瘤术前应用GnRH-a 3个月,可明显缩小肌瘤体积,缩短手术时间,减少术中出血量。

Objective

Analyse about the effect, application and the contraindication of GnRH-a agonist therapy before laparoscopic hysteromyomectomy.

Methods

A retrospective study of laparoscopic hysteromyomectomy of the leiomyoma is longer than 5 cm. Of them 28 cases given GnRH-a(investigation group),36 cases without any disposal(comparison group), compare the operation time, bleeding quantity and the operation syndrome of the 2 groups.

Results

①In the investigation group, every case includes 1 〜2 leiomyoma, aggregately 32 leiomyoma was excised. Without any drug diameter of the average leiomyoma is 6. 5 cm, after the resection the diameter of the average leiomyoma is 3. 2 cm; in the comparison group, every case 1〜3 leiomyoma. Without any drug diameter of the average leiomyoma is 5. 9 cm, after the resection the average diameter of the leiomyoma is 5. 7 cm. Before the operation there's no notable difference between the 2 groups of the diameter(P>0. 05). After the operation, the diameter of the investigation group is remarkably shorten. There's notable difference(P< 0. 01).② In the investigation group, there are 9 cases were sewed up, operation time is(45±18)minutes and average bleeding quantity is(60±25)ml. In the comparison group, there are 12 cases were sewed up, operation time is(92 ± 32)minutes and average bleeding quantity is(110± 105)ml. The operation time and the bleeding quantity of the investigation group is remarkably reduced(P <0. 01, P < 0. 05). ③ the investigation group and the comparison group treatment time is separately 4. 2 and 4. 8 days. 2 months after the operation, the sufferers of 2 groups both mended. 1 case of the investigation group was resected with celioscope again in 1+ year.

Conclusion

Applying GnRH-a 3 months before the operation to those bigger leiomyoma can remarkably reduce the volume of the leiomyoma, operation time and bleeding quantity.

1 曹泽毅.中华妇产科学.第2版.北京:人民卫生出版社,2004,2082-2101.
2 Filicori M, Hall DA,Loughlin JS,et al. A conservative approach to management of uterine leiomyoma:pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol,1983,147:726-727.
3 李丽华,王秀云.手术前应用促性腺激素类似物用于子宫肌瘤合并贫血的治疗.中华妇产科杂志,1998,33:563-564.
4 Chabbert-Buffet N. GnRH antagonists. Clin Obstet Gynecol,2003,46(2):254-264.
5 Zullo F,Pellicano M,Di Carlo C,et al. Ultrasonographic prediction of the efficacy of GnRH agonist therapy before laparoscopic myomectomy. J Am Assoc Laparosc,1998,5:362.
6 乐杰.妇产科学.第5版.北京:人民卫生出版社,2000,323-333.
7 Balasch J,Mimo J. Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma. Acta Obstet Gynaecol Scand, 1995,74:562-565.
8 刘新民.妇产科手术学.第3版.北京:人民卫生出版社,2003,204-213.
9 Vercellini P, Crosignani PG, Mangioni C, et al. Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyoma:results of a multicentre, randomized controlled trial. Br J Obstet Gynecol, 1998,105:1158-1164.
10 Ito F, Kawamura N, Ichimura T,et al. Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment. Fertil Steril,2001,75:125-130.
11 Di Lieto A, De Falco M, Staibano S, et al. Effects of gonadotropinreleasing hormone agonist on uterine volume and vasculature and on the immunohistochemical expression of basic fibroblast growth factor in uterine leiomyomas. Int Gynecol Pathol, 2003,22:353-358.
12 Palomba S, Affinito P,Tommaselli GA, et al. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of the uterine leiomyomata. Fertil Steril,1998,70.111-118.
13 许燕雪,张友忠.GnRH-a与小剂量利维爱反加疗法在治疗子宫内膜异位症中的应用.现代妇产科进展,2003,12:120-123.
14 Tulandi T,Al-Took S. Endoscopic myomectomy-Laparoscopy and hysteroscopy. Obstet Gynecol Clin North Am, 1999,26:135.
15 Nazhat L, Roemisch T, Nezhat C, et at. Recurrence rate after laparoscopic myomectomy. J Mn Assoc Gynecol Lparosc,1998,5: 237.
[1] 吴萍, 陈艳, 陈丰华, 张立晶. 聚焦超声消融对阔韧带子宫肌瘤的临床疗效[J]. 中华医学超声杂志(电子版), 2021, 18(12): 1203-1207.
[2] 吕祝英, 黄品同, 雷志锴, 楼军, 孔凡雷, 陈龙. 超声引导经皮穿刺聚桂醇硬化治疗症状性子宫肌瘤的临床应用[J]. 中华医学超声杂志(电子版), 2021, 18(10): 991-997.
[3] 刘慧, 张晶, 张冰松, 韩治宇, 徐瑞芳, 李秀梅. 超声引导经皮微波消融子宫肌瘤及腺肌病治疗中及远期超声声像图表现[J]. 中华医学超声杂志(电子版), 2016, 13(02): 113-116.
[4] 赵秀敏, 李杰, 彭洋颖, 姜健慧. 子宫腺肌病患者CXCL12/CXCR4/CXCR7 mRNA及其蛋白表达水平[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(03): 309-315.
[5] 游小林, 干晓琴, 黄利琼, 张家佳, 张强, 黄璐, 袁薇, 李娟. 子宫肌瘤原位旋切法在腹腔镜下子宫肌瘤剔除术的应用[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(05): 566-570.
[6] 李艺平, 颜友良, 王秀中, 钟亮尹, 钟洁. 开腹与腹腔镜下子宫肌瘤剔除术的对比研究[J]. 中华妇幼临床医学杂志(电子版), 2017, 13(01): 61-64.
[7] 刘丹. 子宫肌瘤剔除术后切口感染相关因素及心理干预研究[J]. 中华实验和临床感染病杂志(电子版), 2017, 11(06): 613-616.
[8] 罗曼文, 黄桔园, 刘艳燕, 易跃雄, 陈雨柔, 熊家强, 王景涛, 张蔚. 单孔腹腔镜子宫肌瘤旋切隔离保护技术的应用[J]. 中华腔镜外科杂志(电子版), 2023, 16(04): 220-226.
[9] 金贝贝, 张玉泉, 李季, 高赛楠, 朱春玉, 丁晓颖, 杨晓清. 普通及机器人辅助经脐单孔腹腔镜在子宫肌瘤剔除术中的应用比较[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 163-167.
[10] 吴纯华, 符华影, 李钰彦, 刘启煌, 关小明, 刘娟. 经阴道单孔腹腔镜子宫肌瘤剔除术的应用[J]. 中华腔镜外科杂志(电子版), 2019, 12(03): 176-178.
[11] 吉梅, 朱一萍, 葛蓓蕾, 隋孟松, 张彦丽, 顾磊, 孙静. 后入路法经阴道自然腔道内镜子宫肌瘤切除术的临床研究[J]. 中华腔镜外科杂志(电子版), 2019, 12(03): 138-141.
[12] 孙凤兰, 周萍, 程兴璞, 张倩倩. 腹腔镜全子宫切除术对子宫肌瘤患者机体氧化应激损伤及术后并发症的影响[J]. 中华临床医师杂志(电子版), 2023, 17(02): 149-153.
[13] 穆永旭, 瞿红英, 刘海艳, 张磊, 金昌, 闫瑞强. 无痛性子宫动脉栓塞术介入治疗子宫肌瘤48例临床观察[J]. 中华介入放射学电子杂志, 2016, 04(01): 24-26.
[14] 刘海艳, 闫瑞强, 李启民, 张磊, 何俊峰, 穆永旭. 子宫肌瘤介入治疗的临床效果观察[J]. 中华介入放射学电子杂志, 2015, 03(04): 195-198.
[15] 刘珊珊, 张煦, 谭晓嫦, 沈敏, 黄联庆, 罗喜平. 高强度聚焦超声治疗腹型肥胖子宫肌瘤患者的临床效果及初步经验[J]. 中华肥胖与代谢病电子杂志, 2019, 05(03): 137-141.
阅读次数
全文


摘要